Evidence map›Paper›PMID 31295578›Full record

ArticleMatrix biology : journal of the International Society for Matrix Biology2020

Peptide gels of fully-defined composition and mechanics for probing cell-cell and cell-matrix interactions in vitro.

J C Ashworth, J L Thompson, J R James, C E Slater, S Pijuan-Galitó, K Lis-Slimak, R J Holley, K A Meade, A Thompson, K P Arkill and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Matrix biology : journal of the International Society for Matrix Biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Journal of the American Chemical Society · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Click chemistry functionalization of self-assembling peptide hydrogels.Journal of biomedical materials research. Part A · 2023
    Article
  15. Article
  16. Development of anF1000Research · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

J C AshworthStem Cell Glycobiology Group, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, UK; Manchester Cancer Research Centre, Division of Molecular & Clinical Cancer Sciences, University of Manchester, UK. Electronic address: jennifer.ashworth@nottingham.ac.uk.
J L ThompsonStem Cell Glycobiology Group, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, UK.
J R JamesStem Cell Glycobiology Group, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, UK.
C E SlaterStem Cell Glycobiology Group, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, UK.
S Pijuan-GalitóStem Cell Glycobiology Group, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, UK; Laboratory of Biophysics and Surface Analysis, School of Pharmacy, University of Nottingham, UK.
K Lis-SlimakStem Cell Glycobiology Group, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, UK.
R J HolleyStem Cell and Neurotherapies Group, University of Manchester, UK.
K A MeadeOffice of Business Relations, Faculty of Biology, Medicine and Health, University of Manchester, UK.
A ThompsonDivision of Cancer & Stem Cells, School of Medicine, University of Nottingham, UK.
K P ArkillDivision of Cancer & Stem Cells, School of Medicine, University of Nottingham, UK.
M TassieriDivision of Biomedical Engineering, School of Engineering, University of Glasgow, UK.
A J WrightOptics and Photonics Research Group, Faculty of Engineering, University of Nottingham, UK.
G FarnieManchester Cancer Research Centre, Division of Molecular & Clinical Cancer Sciences, University of Manchester, UK; SGC, Botnar Research Centre, NDORMS, University of Oxford, UK. Electronic address: gillian.farnie@ndorms.ox.ac.uk.
C L R MerryStem Cell Glycobiology Group, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, UK. Electronic address: cathy.merry@nottingham.ac.uk.
University of Nottingham · GBUniversity of Manchester · GBUniversity of Glasgow · GB

Funding

Medical Research Council MR/M02492X/1Medical Research Council MR/P003214/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/N001583/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/T001259/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/T001267/1Wellcome Trust 201457/Z/16/Z
6 · The paper itself

Abstract

Current materials used for in vitro 3D cell culture are often limited by their poor similarity to human tissue, batch-to-batch variability and complexity of composition and manufacture. Here, we present a "blank slate" culture environment based on a self-assembling peptide gel free from matrix motifs. The gel can be customised by incorporating matrix components selected to match the target tissue, with independent control of mechanical properties. Therefore the matrix components are restricted to those specifically added, or those synthesised by encapsulated cells. The flexible 3D culture platform provides full control over biochemical and physical properties, allowing the impact of biochemical composition and tissue mechanics to be separately evaluated in vitro. Here, we demonstrate that the peptide gels support the growth of a range of cells including human induced pluripotent stem cells and human cancer cell lines. Furthermore, we present proof-of-concept that the peptide gels can be used to build disease-relevant models. Controlling the peptide gelator concentration allows peptide gel stiffness to be matched to normal breast (<1 kPa) or breast tumour tissue (>1 kPa), with higher stiffness favouring the viability of breast cancer cells over normal breast cells. In parallel, the peptide gels may be modified with matrix components relevant to human breast, such as collagen I and hyaluronan. The choice and concentration of these additions affect the size, shape and organisation of breast epithelial cell structures formed in co-culture with fibroblasts. This system therefore provides a means of unravelling the individual influences of matrix, mechanical properties and cell-cell interactions in cancer and other diseases.

Indexed as

AnimalsBreastBreast NeoplasmsCell CommunicationCell LineCell ProliferationCell SurvivalCoculture TechniquesExtracellular MatrixFemaleFibroblastsHCT116 CellsHumansHydrogelsMCF-7 CellsMiceHydrogelsPeptidesBiomaterialsCancerExtracellular matrixStem cellsStiffness

Identifiers

PMID31295578
PMCPMC7610915
OpenAlexW2953843493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.